Strategist PLGA Nano-capsules to Deliver siRNA for Inhibition of Carcinoma and Neuroblastoma Cell Lines by Knockdown of MYC Proto-oncogene using CPPs and PNA

Journal Title: NanoWorld Journal - Year 2015, Vol 1, Issue 2

Abstract

RNA interference and the therapeutic applications using small interfering RNA was discovered more than 10 years ago and currently is used in various applications including in therapeutic field. However the research in this field is still in its infancy. Many challenges like safe delivery of targeted siRNA to nucleus and cytosol of cancerous cells without compromising the activity of siRNA needs to be addressed. We have overcome this hurdle with the help of nanotechnology using PLGA hollow nanoparticles (PLGAHNPs) and suppressing the oncogene of MYC transcription factors by using anti myc-siRNAs in human cancer cell lines. siRNA was encapsulated in PLGAHNPs. These spherical PLGAHNPs of size 70 nm had high efficiency of gene release at pH 4.2 under in vitro conditions. Cell penetrating peptide (CPP)- Tat peptide (TAT) and peptide nucleic acidnucleolus localizing signal (PNA-NLS) was used for siRNA delivery without affecting the therapeutic activity of siRNA. The siRNA duplex was prepared using T7 polymerase and double stranded DNA through in vitro transcription. Incubation of the siRNA encapsulated PLGAHNPs functionalized with TAT and PNA-NLS (TAT-siRNA-PNA-PLGAHNPs-siRNA) with cancer cells resulted in reduced cell proliferation. A downregulation of gene expression by 90% was observed even with low concentration of siRNA. We found complete arrest of cell division which was mediated by downregulation of MYC expression.

Authors and Affiliations

Archana Raichur, Yoshikata Nakajima, Yutaka Nagaoka, Kotaro Matsumoto, Toru Mizuki, Kazunori Kato, D. Sakthi Kumar

Keywords

Related Articles

Proceedings of the 2nd NanoWorld Conference in Boston (NWC-2017). Part II: Plenary Symposia

The inherent need for enhanced autonomy in space systems with dramatically reduced size, weight, and power is directly benefitting from the rapid advances in microelectronics driven primarily by commercial forces in this...

Introduction: Proceedings of the 2nd NanoWorld Conference in Boston (NWC-2017)

From April 3 to 5, 2017 in Newton (Boston, USA) we set the second NanoWorld Conference (NWC) around the theme “Useful Science and Technology for a Just World” to focus on progresses in Nanotechnology and Nanosciences cap...

Langmuir-Blodgett Technology for Drugs Production and Delivery: Insights and Implications from an In Silico Study

Insulin dynameomics here reported as a database pertaining to a series of Molecular Dynamics (MD) ran for Protein Data Bank (PDB) entries consisting in bioinformatics and molecular dynamics simulation of Langmuir-Blodget...

Acknowledgement of Manuscript Reviewers NWJ Volume-1 (2015)

The Editors of NanoWorld Journal (NWJ) would like to express their tremendous gratitude to all those individuals who participated in the peer review process during the preparation of this Volume-1 (2015). Many reviewers...

Nanoprobe NAPPA Arrays for the Nanoconductimetric Analysis of Ultra-Low-Volume Protein Samples Using Piezoelectric Liquid Dispensing Technology

In the last years, the evolution and the advances of the nanobiotechnologies applied to the systematic study of proteins, namely proteomics, both structural and functional, and specifically the development of more sophis...

Download PDF file
  • EP ID EP223085
  • DOI 10.17756/nwj.2015-005
  • Views 122
  • Downloads 0

How To Cite

Archana Raichur, Yoshikata Nakajima, Yutaka Nagaoka, Kotaro Matsumoto, Toru Mizuki, Kazunori Kato, D. Sakthi Kumar (2015). Strategist PLGA Nano-capsules to Deliver siRNA for Inhibition of Carcinoma and Neuroblastoma Cell Lines by Knockdown of MYC Proto-oncogene using CPPs and PNA. NanoWorld Journal, 1(2), 32-45. https://europub.co.uk/articles/-A-223085